Aug 21, 1976

Prognostic significance of in-vitro complement fixation in liver biopsy specimens from patients with acute viral hepatitis type B

Lancet
M RizzettoG Verme

Abstract

The prognostic significance of in-vitro complement fixation (V.C.F.) by hepatitis-B core antigen/antibody immunocomplexes in hepatitis-B surface antigen (HBsAg) positive liver biopsy specimens was prospectively evaluated in 47 patients presenting with acute viral hepatitis type B. 34 of 37 V.C.F.-negative patients made an uneventful recovery and became HBsAg negative; in all patients with a V.C.F.-positive test chronic hepatitis and persistent antigenaemia developed. The V.C.F. test is a simple and reliable prognostic indicator of persistent infection and of progression of apparently acute hepatitis to a chronic liver disorder.

  • References
  • Citations6

References

  • We're still populating references for this paper, please check back later.

Mentioned in this Paper

End Stage Liver Disease
Hepatitis
Acute Disease
Hepatitis B antigen peptide
Persistent Infection
Liver Diseases
Antigens
Hepatitis B Surface Antigens
Immune complex
Hepatitis B Surface Antigen Measurement

About this Paper

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.